Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners.

The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U ...

A group of more than two dozen members of Congress penned a letter to Attorney General William Barr Nov. 10, urging him to reject part of the Justice Department’s opioid settlement with Purdue Pharma. Part of the settlement, announced Oct. 21, involves ...

OxyContin maker Purdue Pharma and a group of states have not been able to agree on a multibillion-dollar settlement of lawsuits over the drug’s role in the opioid crisis after more than a month of mediation. A mediator could call for still more talks ...

All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced Monday. The settlement resolves pending litigation against ...

The Sackler family, owners of OxyContin maker Purdue Pharma, has agreed to pay $6 billion to settle long-running litigation alleging they fueled the nation’s opioid epidemic, The New York Times reported March 3. After three years of negotiations, this ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The attorneys general for eight holdout states and the District of Columbia are close to reaching a ...

The Supreme Court on Thursday blew up the massive bankruptcy reorganization of opioid maker Purdue Pharma, finding that the settlement inappropriately included legal protections for the Sackler family, meaning that billions of dollars secured for victims ...